Quidel Stock Math Transform Exponential Price Movement

QDEL Stock  USD 17.10  -0.82  -4.58%   
The math transform module provides an execution environment for Exponential Price Movement transformation and related indicators on Quidel. Signals here center on price transformations that reveal shifts in trend structure alongside volatility and performance references.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Quidel Price Movement is a mathematical transformation function to describe exponentially increasing price patterns.

Quidel Technical Analysis Modules

Most technical analysis of Quidel help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Quidel from various momentum indicators to cycle indicators. When you analyze Quidel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Stock Overview, Methodology & Data Sources

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company was founded in 1979 and is headquartered in San Diego, California. Quidelortho Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1600 people. The profile for Quidel integrates fundamentals, price behavior, and sector exposure. Price behavior may show elevated responsiveness to broader market cycles. Quidel has a market cap of 1.16 B, P/E of 5.56, ROE of -46.15%.

Methodology

Unless otherwise specified, financial data for Quidel is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Quidel (USA Stocks:QDEL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Quidel is covered by 7 analysts. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include HSBC Global Research, Wells Fargo Securities, Goldman Sachs, Guggenheim Securities, RBC Capital Markets, Citigroup, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board

Be your own money manager

Tracking Quidel inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing risk tolerance and investment horizon, Macroaxis optimization evaluates acceptable risk for target return profiles. The process summarizes how much risk can be taken for a given return goal.

More Resources for Quidel Stock Analysis

A structured review of Quidel often starts with core financial statements and trend context. Ratios and trend metrics help frame Quidel's operating context. Key reports that frame Quidel Stock are listed below:
Quidel has a market cap of 1.16 B, operating margin of 4.01%, ROE of -46.15%. Use Your Equity Center to explore allocation context. This includes a position in Quidel in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
To learn how to invest in Quidel Stock, please use our How to Invest in Quidel guide.
Analysis related to Quidel should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
 Quarterly Earnings Growth
-0.77
 Earnings Share
-16.69
 Revenue Per Share
40.268
 Quarterly Revenue Growth
0.022
 Return On Assets
0.0127
The market value of Quidel is measured differently than book value, which reflects Quidel accounting equity. Quidel's market capitalization is 1.16 B. A P/B ratio of 0.61 suggests Quidel trades near or below book value. Enterprise value stands at 3.83 B. Value and price for Quidel are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that Quidel's intrinsic value and market price are different measures derived from different inputs. For Quidel, key inputs include a P/E ratio of 5.56, a P/B ratio of 0.61, a profit margin of -41.46%, and ROE of -46.15%. Market price reflects the current exchange level formed by active bids and offers.